Zobrazeno 1 - 10
of 66 001
pro vyhledávání: '"Injections subcutaneous"'
Autor:
Green P; Chesapeake Pharma LLC, Weehawken, NJ, USA., Schneider A; Delivery Systems, Ypsomed AG, Burgdorf, Switzerland., Lange J; Delivery Systems, Ypsomed AG, Burgdorf, Switzerland.
Publikováno v:
MAbs [MAbs] 2024 Jan-Dec; Vol. 16 (1), pp. 2402713. Date of Electronic Publication: 2024 Sep 15.
Autor:
Purcell J; Mallinckrodt Pharmaceuticals, Bridgewater, NJ 08807, USA., Elliott S; Mallinckrodt Pharmaceuticals, Bridgewater, NJ 08807, USA.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2024 Dec; Vol. 13 (12), pp. e240132. Date of Electronic Publication: 2024 Oct 25.
Autor:
Koenitz L; SSPC, the SFI Research Centre for Pharmaceuticals, School of Pharmacy, University College Cork, Cork T12 YT20, Ireland. Electronic address: laurakoenitz@umail.ucc.ie., Crean A; SSPC, the SFI Research Centre for Pharmaceuticals, School of Pharmacy, University College Cork, Cork T12 YT20, Ireland., Vucen S; SSPC, the SFI Research Centre for Pharmaceuticals, School of Pharmacy, University College Cork, Cork T12 YT20, Ireland.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Nov; Vol. 204, pp. 114517. Date of Electronic Publication: 2024 Sep 28.
Autor:
Ahn HS; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, Korea., Kim HM; Maylin Clinic, Goyang, Gyeonggi-do, Korea., Oh W; Maylin Clinic, Seoul, Korea., Yi KH; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, Korea.; Maylin Clinic, Apgujeong Seoul, Korea., Kim J; Dr Youth clinic, Seoul, Korea., Kim HJ; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, Korea.; Department of Electric and Electronical Engineering, College of Engineering, Yonsei University, Seoul, Korea.
Publikováno v:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Oct; Vol. 23 (10), pp. 3195-3201. Date of Electronic Publication: 2024 Jun 04.
Autor:
McKeage JW; Auckland Bioengineering Institute, the University of Auckland, Auckland, New Zealand. Electronic address: james.mckeage@auckland.ac.nz., Tan AZH; Auckland Bioengineering Institute, the University of Auckland, Auckland, New Zealand., Taberner AJ; Auckland Bioengineering Institute, the University of Auckland, Auckland, New Zealand; Department of Engineering Science, Faculty of Engineering, the University of Auckland, Auckland, New Zealand.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Dec 25; Vol. 667 (Pt A), pp. 124887. Date of Electronic Publication: 2024 Oct 28.
Autor:
Wanselius M; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden., Abrahmsén-Alami S; Innovation Strategy & External Liaison. Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden., Hanafy BI; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Cambridge, United Kingdom., Mazza M; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Cambridge, United Kingdom., Hansson P; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden. Electronic address: per.hansson@ilk.uu.se.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Dec 25; Vol. 667 (Pt A), pp. 124849. Date of Electronic Publication: 2024 Oct 24.
Autor:
Feldman SR; Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA., Narbutt J; Dermoklinika Centrum Medyczne s.c. M. Kierstan, J. Narbutt, A. Lesiak, Łódź, Poland., Girolomoni G; Division of Dermatology, Department of Medicine, University of Verona, Verona, Italy., Brzezicki J; Centrum Kliniczno Badawcze J. Brzezicki, B. Gornikiewicz-Brzezicka Lekarze Spolka Partnerska, Elbląg, Poland., Reznichenko N; Therapeutic Department, Military Hospital (Military Unit A3309) of Military Medical Clinical Center of Eastern Region, Zaporizhzhia, Ukraine., Zegadło-Mylik MA; ETG WARSZAWA, Warsaw, Poland., Pulka G; Grazyna Pulka Centrum Medyczne All-med Badania Kliniczne, Kraków, Poland., Dmowska-Stecewicz M; ETG Siedlce, Siedlce, Poland., Kłujszo E; Prywatny Gabinet Dermatologiczny Elżbieta Kłujszo, Kielce, Poland., Rekalov D; Medical Center of LLC 'Suchasna klinika', Zaporizhzhia, Ukraine., Rajzer L; L.Rajzer Specjalistyczny Gabinet Dermatologiczno-Kosmetyczny, Kraków, Poland., Lee J; Samsung Bioepis, Co. Ltd, Incheon, South Korea., Lee M; Samsung Bioepis, Co. Ltd, Incheon, South Korea., Rho YH; Samsung Bioepis, Co. Ltd, Incheon, South Korea.
Publikováno v:
The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2436607. Date of Electronic Publication: 2024 Dec 10.
Autor:
Mueller LE; Protagenic Therapeutics Inc., New York, New York, USA., Wexler RS; NeoSome Life Science, Lexington, Massachusetts, USA., Lovejoy DA; Protagenic Therapeutics Inc., New York, New York, USA.; Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada., Stein RB; Protagenic Therapeutics Inc., New York, New York, USA., Slee AM; Protagenic Therapeutics Inc., New York, New York, USA.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Dec; Vol. 12 (6), pp. e70045.
Autor:
Hu S; Phase I Clinical Trial Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology; Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, 430023, China., Liu Y; Clinical Medicine Center, China National Biotec Group Company Limited, Beijing, 100029, China., Yang L; Antibody Research Department, Wuhan Institute of Biological Products Co. Ltd., Wuhan, 430207, China., Yang Y; Clinical Medicine Center, China National Biotec Group Company Limited, Beijing, 100029, China., Long F; Clinical Medicine Center, China National Biotec Group Company Limited, Beijing, 100029, China., Bao H; Clinical Medicine Center, China National Biotec Group Company Limited, Beijing, 100029, China., Zhang H; Clinical Medicine Center, China National Biotec Group Company Limited, Beijing, 100029, China., Yue X; Antibody Research Department, Wuhan Institute of Biological Products Co. Ltd., Wuhan, 430207, China., Zhang J; Antibody Research Department, Wuhan Institute of Biological Products Co. Ltd., Wuhan, 430207, China., Wang Z; Antibody Research Department, Wuhan Institute of Biological Products Co. Ltd., Wuhan, 430207, China., Huang C; Phase I Clinical Trial Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology; Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, 430023, China., Wang J; Phase I Clinical Trial Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology; Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, 430023, China., Xia L; Phase I Clinical Trial Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology; Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, 430023, China., Pan Y; Antibody Research Department, Wuhan Institute of Biological Products Co. Ltd., Wuhan, 430207, China. yongbingpan@163.com., Zhang Y; Clinical Medicine Center, China National Biotec Group Company Limited, Beijing, 100029, China. zhangyuntao@sinopharm.com., Gong F; Phase I Clinical Trial Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology; Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, 430023, China. 2020jy0008@hust.edu.cn.
Publikováno v:
Clinical drug investigation [Clin Drug Investig] 2024 Dec; Vol. 44 (12), pp. 951-960. Date of Electronic Publication: 2024 Nov 15.
Autor:
Hadden RDM; Neurology Department, King's College Hospital, London, UK.; Department of Basic & Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Andersen H; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark., Bril V; The Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada., Basta I; Faculty of Medicine, Neurology Clinic, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia., Rejdak K; Department of Neurology, Medical University of Lublin, Lublin, Poland., Duff K; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Greco E; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Hasan S; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Anderson-Smits C; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Ay H; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.
Publikováno v:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2024 Dec; Vol. 29 (4), pp. 441-452. Date of Electronic Publication: 2024 Nov 11.